Complete Genome Sequence of Neonatal Clinical Group B Streptococcal Isolate CJB111-Reference-Cited by-同舟云学术

Complete Genome Sequence of Neonatal Clinical Group B Streptococcal Isolate CJB111

Published:2021-01-14 Issue:2 Volume:10 Page:
ISSN:2576-098X
Container-title:Microbiology Resource Announcements
language:en
Short-container-title:Microbiol Resour Announc

Author:

Spencer Brady L.¹^ORCID,Chatterjee Anushila¹,Duerkop Breck A.¹^ORCID,Baker Carol J.²³,Doran Kelly S.¹^ORCID

Affiliation:

1. Department of Immunology and Microbiology, School of Medicine, University of Colorado-Anschutz Medical Center, Aurora, Colorado, USA

2. Department of Pediatrics, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA

3. Children’s Memorial Hermann Hospital, Houston, Texas, USA

Abstract

Group B Streptococcus (GBS) is an asymptomatic colonizer of the female reproductive tract but can cause maternal and neonatal infections and adverse pregnancy outcomes. Here, we closed the genome sequence of strain CJB111, a neonatal GBS clinical isolate from a case of late-onset bacteremia without focus (Houston, TX; 1990).

Funder

HHS | NIH | National Institute of Allergy and Infectious Diseases

HHS | NIH | National Institute of Neurological Disorders and Stroke

Publisher

American Society for Microbiology

Subject

Genetics,Immunology and Microbiology (miscellaneous),Molecular Biology

Link

https://journals.asm.org/doi/pdf/10.1128/MRA.01268-20

Reference17 articles.

1. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010;Verani JR;MMWR Recomm Rep,2010

2. Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children